Trisalus Life Sciences earnings were -$55.5M for the trailing 12 months ending Sep 30, 2024, with N/A growth year over year. The latest TLSI earnings report on Sep 30, 2024 announced Q3 2024 earnings of -$2.4M, down 44.6% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, TLSI reported annual earnings of -$59.0M, with 25.1% growth.
Trisalus Life Sciences Earnings Reports & History FAQ
What were Trisalus Life Sciences's earnings last quarter?
Trisalus Life Sciences (NASDAQ: TLSI) reported Q3 2024 earnings per share (EPS) of -$0.12, up 14.29% year over year. Total TLSI earnings for the quarter were -$2.40 million. In the same quarter last year, Trisalus Life Sciences's earnings per share (EPS) was -$0.14.
Is Trisalus Life Sciences profitable or losing money?
As of the last Trisalus Life Sciences earnings report, Trisalus Life Sciences is currently losing money. Trisalus Life Sciences's net profit (also called net income) for the twelve months ending Sep 30, 2024 was -$55.46 million, a 20.02% increase year over year.
What was TLSI's earnings growth in the past year?
As of Trisalus Life Sciences's earnings date in Q1 2025, Trisalus Life Sciences's earnings has grown year over year. TLSI earnings in the past year totalled -$55.46 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.